North America Hematology Market Outlook to 2024

Published : Dec-2017

No. of Pages : 305

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Hematology Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Hematology Market, North America 13
3.1 Hematology Market, North America, Revenue ($m), 2010-2024 13
3.2 Hematology Market, North America, Category Comparison by Revenue ($m), 2010-2024 15
3.3 Hematology Market, North America, Revenue ($m), 2010-2017 17
3.4 Hematology Market, North America, Revenue ($m), 2017-2024 19
3.5 Hematology Market, North America, Volume (Units), 2010-2024 21
3.6 Hematology Market, North America, Volume (Units), 2010-2017 23
3.7 Hematology Market, North America, Volume (Units), 2017-2024 25
3.8 Hematology Market, North America, Company Share by Revenue ($m), 2017 27
4 Hematology Market, Canada 29
4.1 Hematology Market, Canada, Revenue ($m), 2010-2017 29
4.2 Hematology Market, Canada, Revenue ($m), 2017-2024 31
4.3 Hematology Market, Canada, Volume (Units), 2010-2017 57
4.4 Hematology Market, Canada, Volume (Units), 2017-2024 59
4.5 Hematology Market, Canada, Average Price ($), 2010-2024 77
4.6 Hematology Market, Canada, Distribution Share by Revenue ($m), 2017 81
4.7 Hematology Market, Canada, Company Share by Revenue ($m), 2017 82
5 Hematology Market, Mexico 84
5.1 Hematology Market, Mexico, Revenue ($m), 2010-2017 84
5.2 Hematology Market, Mexico, Revenue ($m), 2017-2024 86
5.3 Hematology Market, Mexico, Volume (Units), 2010-2017 112
5.4 Hematology Market, Mexico, Volume (Units), 2017-2024 114
5.5 Hematology Market, Mexico, Average Price ($), 2010-2024 132
5.6 Hematology Market, Mexico, Distribution Share by Revenue ($m), 2017 136
5.7 Hematology Market, Mexico, Company Share by Revenue ($m), 2017 137
6 Hematology Market, United States 139
6.1 Hematology Market, United States, Revenue ($m), 2010-2017 139
6.2 Hematology Market, United States, Revenue ($m), 2017-2024 141
6.3 Hematology Market, United States, Volume (Units), 2010-2017 167
6.4 Hematology Market, United States, Volume (Units), 2017-2024 169
6.5 Hematology Market, United States, Average Price ($), 2010-2024 187
6.6 Hematology Market, United States, Distribution Share by Revenue ($m), 2017 191
6.7 Hematology Market, United States, Company Share by Revenue ($m), 2017 192
7 Overview of Key Companies in North America Hematology Market 194
7.1 Sysmex Corp 194
7.2 F. Hoffmann-La Roche Ltd 194
7.3 Beckman Coulter Inc 194
7.4 Abbott Laboratories 194
7.5 Horiba Ltd 195
7.6 Siemens Healthcare GmbH 195
7.7 Sigma-Aldrich Corp 195
7.8 Instrumentation Laboratory Company 195
7.9 Thermo Fisher Scientific Inc 196
7.10 bioMerieux SA 196
7.11 Mindray Medical International Ltd 196
7.12 Sekisui Diagnostics LLC 196
7.13 Bio-Rad Laboratories Inc 197
7.14 Becton Dickinson and Co 197
7.15 Immucor, Inc. 197
8 Hematology Market Pipeline Products 198
9 Recent Developments 199
9.1 Corporate Communications 199
9.2 Financial Announcements 217
9.3 Government and Public Interest 279
9.4 Legal And Regulatory 281
9.5 Other Significant Developments 284
9.6 Product News 290
9.7 Strategy And Business Planning 292
10 Appendix 295
10.1 Research Methodology 296
10.2 GlobalData Consulting 300
10.3 Contact Us 301
10.4 Disclaimer 301

1.1 List of Tables
Table 1: Hematology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 18
Table 2: Hematology Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 20
Table 3: Hematology Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 22
Table 4: Hematology Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 24
Table 5: Hematology Market, North America, Volume (Units), 2010-2024 26
Table 6: Hematology Market, North America, Volume (Units), Historic, 2010-2017 28
Table 7: Hematology Market, North America, Volume (Units), Forecast, 2017-2024 30
Table 8: Hematology Market, North America, Company Share by Revenue ($m), USD Constant, 2017 32
Table 9: Hematology Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 34
Table 10: Hematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 36
Table 11: Hematology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 38
Table 12: Hematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 13: Hematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 42
Table 14: Hematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 44
Table 15: Hemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 46
Table 16: Immunohematology Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 48
Table 17: Hematology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 50
Table 18: Hematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 52
Table 19: Hematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 20: Hematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 56
Table 21: Hemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 58
Table 22: Immunohematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 60
Table 23: Hematology Market, Canada, Volume (Units), Historic, 2010-2017 62
Table 24: Hematology Market, Canada, Volume (Units), Forecast, 2017-2024 64
Table 25: Hematology Analyzers Market, Canada, Volume (Units), Historic, 2010-2017 66
Table 26: Hematology Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 68
Table 27: Hematology Reagents Market, Canada, Volume (Units), Historic, 2010-2017 70
Table 28: Hemostasis Market, Canada, Volume (Units), Historic, 2010-2017 72
Table 29: Hematology Analyzers Market, Canada, Volume (Units), Forecast, 2017-2024 74
Table 30: Hematology Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 76
Table 31: Hematology Reagents Market, Canada, Volume (Units), Forecast, 2017-2024 78
Table 32: Hemostasis Market, Canada, Volume (Units), Forecast, 2017-2024 80
Table 33: Hematology Market, Canada, Average Price ($) Historic, 2010-2017 81
Table 34: Hematology Market, Canada, Average Price ($), Forecast, 2017-2024 83
Table 35: Hematology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 85
Table 36: Hematology Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 87
Table 37: Hematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 89
Table 38: Hematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 91
Table 39: Hematology Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 93
Table 40: Hematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 95
Table 41: Hematology Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 97
Table 42: Hematology Reagents Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 99
Table 43: Hemostasis Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 101
Table 44: Immunohematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 103
Table 45: Hematology Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 105
Table 46: Hematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 107
Table 47: Hematology Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 109
Table 48: Hematology Reagents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 111
Table 49: Hemostasis Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 113
Table 50: Immunohematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 115
Table 51: Hematology Market, Mexico, Volume (Units), Historic, 2010-2017 117
Table 52: Hematology Market, Mexico, Volume (Units), Forecast, 2017-2024 119
Table 53: Hematology Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 121
Table 54: Hematology Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 123
Table 55: Hematology Reagents Market, Mexico, Volume (Units), Historic, 2010-2017 125
Table 56: Hemostasis Market, Mexico, Volume (Units), Historic, 2010-2017 127
Table 57: Hematology Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 129
Table 58: Hematology Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 131
Table 59: Hematology Reagents Market, Mexico, Volume (Units), Forecast, 2017-2024 133
Table 60: Hemostasis Market, Mexico, Volume (Units), Forecast, 2017-2024 135
Table 61: Hematology Market, Mexico, Average Price ($) Historic, 2010-2017 136
Table 62: Hematology Market, Mexico, Average Price ($), Forecast, 2017-2024 138
Table 63: Hematology Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 140
Table 64: Hematology Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 142
Table 65: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 144
Table 66: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 146
Table 67: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 148
Table 68: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 150
Table 69: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 152
Table 70: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 154
Table 71: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 156
Table 72: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 158
Table 73: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 160
Table 74: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 162
Table 75: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 164
Table 76: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 166
Table 77: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 168
Table 78: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 170
Table 79: Hematology Market, United States, Volume (Units), Historic, 2010-2017 172
Table 80: Hematology Market, United States, Volume (Units), Forecast, 2017-2024 174
Table 81: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017 176
Table 82: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 178
Table 83: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017 180
Table 84: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017 182
Table 85: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 184
Table 86: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 186
Table 87: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024 188
Table 88: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024 190
Table 89: Hematology Market, United States, Average Price ($) Historic, 2010-2017 191
Table 90: Hematology Market, United States, Average Price ($), Forecast, 2017-2024 193
Table 91: Hematology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 195
Table 92: Hematology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 197
Table 93: Hematology Market Pipeline Products 202
Table 94: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 302

1.2 List of Figures
Figure 1: Hematology Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 17
Figure 2: Hematology Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 19
Figure 3: Hematology Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 21
Figure 4: Hematology Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 23
Figure 5: Hematology Market, North America, Volume (Units), 2010-2024 25
Figure 6: Hematology Market, North America, Volume (Units), Historic, 2010-2017 27
Figure 7: Hematology Market, North America, Volume (Units), Forecast, 2017-2024 29
Figure 8: Hematology Market, North America, Company Share (%) 2017 31
Figure 9: Hematology Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 33
Figure 10: Hematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 35
Figure 11: Hematology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 37
Figure 12: Hematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 39
Figure 13: Hematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 41
Figure 14: Hematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 43
Figure 15: Hemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 45
Figure 16: Immunohematology Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 47
Figure 17: Hematology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 49
Figure 18: Hematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 51
Figure 19: Hematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 53
Figure 20: Hematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 55
Figure 21: Hemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 57
Figure 22: Immunohematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 59
Figure 23: Hematology Market, Canada, Volume (Units), Historic, 2010-2017 61
Figure 24: Hematology Market, Canada, Volume (Units), Forecast, 2017-2024 63
Figure 25: Hematology Analyzers Market, Canada, Volume (Units), Historic, 2010-2017 65
Figure 26: Hematology Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 67
Figure 27: Hematology Reagents Market, Canada, Volume (Units), Historic, 2010-2017 69
Figure 28: Hemostasis Market, Canada, Volume (Units), Historic, 2010-2017 71
Figure 29: Hematology Analyzers Market, Canada, Volume (Units), Forecast, 2017-2024 73
Figure 30: Hematology Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 75
Figure 31: Hematology Reagents Market, Canada, Volume (Units), Forecast, 2017-2024 77
Figure 32: Hemostasis Market, Canada, Volume (Units), Forecast, 2017-2024 79
Figure 33: Hematology Market, Canada, Company Share (%) 2017 86
Figure 34: Hematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 88
Figure 35: Hematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 90
Figure 36: Hematology Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 92
Figure 37: Hematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 94
Figure 38: Hematology Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 96
Figure 39: Hematology Reagents Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 98
Figure 40: Hemostasis Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 100
Figure 41: Immunohematology Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 102
Figure 42: Hematology Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 104
Figure 43: Hematology Cell Counters Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 106
Figure 44: Hematology Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 108
Figure 45: Hematology Reagents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 110
Figure 46: Hemostasis Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 112
Figure 47: Immunohematology Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 114
Figure 48: Hematology Market, Mexico, Volume (Units), Historic, 2010-2017 116
Figure 49: Hematology Market, Mexico, Volume (Units), Forecast, 2017-2024 118
Figure 50: Hematology Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 120
Figure 51: Hematology Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 122
Figure 52: Hematology Reagents Market, Mexico, Volume (Units), Historic, 2010-2017 124
Figure 53: Hemostasis Market, Mexico, Volume (Units), Historic, 2010-2017 126
Figure 54: Hematology Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 128
Figure 55: Hematology Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 130
Figure 56: Hematology Reagents Market, Mexico, Volume (Units), Forecast, 2017-2024 132
Figure 57: Hemostasis Market, Mexico, Volume (Units), Forecast, 2017-2024 134
Figure 58: Hematology Market, Mexico, Company Share (%) 2017 141
Figure 59: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 143
Figure 60: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 145
Figure 61: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 147
Figure 62: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 149
Figure 63: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 151
Figure 64: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 153
Figure 65: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 155
Figure 66: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 157
Figure 67: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 159
Figure 68: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 161
Figure 69: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 163
Figure 70: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 165
Figure 71: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 167
Figure 72: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 169
Figure 73: Hematology Market, United States, Volume (Units), Historic, 2010-2017 171
Figure 74: Hematology Market, United States, Volume (Units), Forecast, 2017-2024 173
Figure 75: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017 175
Figure 76: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 177
Figure 77: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017 179
Figure 78: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017 181
Figure 79: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 183
Figure 80: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 185
Figure 81: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024 187
Figure 82: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024 189
Figure 83: Hematology Market, United States, Company Share (%) 2017 196

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

North America Hematology Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model